Records containing: Neoplasms

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-12-20
  BIBW 2992 Phase I Combination With Pemetrexed in Advanced Solid Tumours
• CLINICAL_TRIALS study record update · 2013-12-02
  Pilot Study on the Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent
• CLINICAL_TRIALS study record update · 2013-11-21
  An Open-label Phase I Single Dose Escalation Trial of Two Dosing Schedules of BI 831266 Administered Intravenously Over 24 h Continuously in Patients With Advanced Solid Tumours
• CLINICAL_TRIALS study record update · 2013-11-20
  A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies
• CLINICAL_TRIALS study record update · 2013-11-19
  Uncontrolled, Open-label, Non-randomized, Phase 1 Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-11-13
  Phase II Open Label Trial to Assess the Efficacy and the Impact on QTcF of Continuous Oral BIBW 2992 at a Daily Dose of 50mg in Patients With Relapsed or Refractory Solid Tumours Including Patients With Brain Metastases and Those With Glioblastoma Not Amenable to Other Therapy
• CLINICAL_TRIALS study record update · 2013-11-05
  Multicenter Phase II Trial of Oxaliplatin and Docetaxel for Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
• CLINICAL_TRIALS study record update · 2013-10-30
  A Randomized, Controlled, Multi-center Collaborative Study to Evaluate the Efficacy of Magnesium Isoglycyrrhizinate Injection in the Prevention of Antineoplastic Chemotherapy Related Acute Liver Injury
• CLINICAL_TRIALS study record update · 2013-10-16
  A Phase Ib Open Label Study to Assess the Safety, Tolerability and Pharmacokinetics of Continuous Dosing With BIBW 2992 Combined With Two Different Regimens of Backbone Chemotherapy: Cisplatin Combined With 5 Fluorouracil and Cisplatin Combined With Paclitaxel in Patients With Advanced Solid Tumors.
• CLINICAL_TRIALS study record update · 2013-10-16
  A Phase I, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Aflibercept in Combination With Intravenous Docetaxel Administered Every 3 Weeks in Patients With Advanced Solid Malignancies
• CLINICAL_TRIALS study record update · 2013-10-14
  An Open Label Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification or EFGR Activating Mutations.
• CLINICAL_TRIALS study record update · 2013-10-10
  Marijuana in Combination With Opioids for Cancer Pain: A Pilot Study
• CLINICAL_TRIALS study record update · 2013-09-12
  A Randomized Controlled Trial of a Robotic Simulation Curriculum to Teach Robotic Suturing
• CLINICAL_TRIALS study record update · 2013-09-05
  A Randomized Controlled Study Comparing the Impact of Prophylactic Versus Deferred Lamivudine on the Delivery of Cytotoxic Chemotherapy in Hepatitis B Surface-antigen Positive Patients With Malignant Solid Tumor
• CLINICAL_TRIALS study record update · 2013-08-14
  A Phase I Multiple Ascending Dose Study of BMS-754807 in Subjects With Advanced or Metastatic Solid Tumors
• CLINICAL_TRIALS study record update · 2013-07-30
  An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY87-2243 Given Once Daily in Subjects With Advanced Malignancies
• CLINICAL_TRIALS study record update · 2013-07-24
  Mindfulness-based Stress Reduction in Supportive Cancer Treatment: Effects of a Day-care Clinic Group Program on Psychometric Parameters in Cancer Patients (Stressbewältigung Durch Achtsamkeit in Der Supportiven Onkologischen Therapie (SASO): Auswirkung Eines Tagesklinischen Gruppenprogramms Auf Psychometrische Parameter Bei Krebspatienten)
• CLINICAL_TRIALS study record update · 2013-05-24
  A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.
• CLINICAL_TRIALS study record update · 2013-05-23
  A Phase I Dose Escalation Study With Sorafenib Administered Continuously in Combination With Docetaxel Administered Once Every Three Weeks in Patients With Advanced Solid Tumors.
• CLINICAL_TRIALS study record update · 2013-05-03
  An Open-label, Phase I, Dose-escalation Study to Characterize the Safety, Tolerability, Pharmacokinetics, and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignancies
• CLINICAL_TRIALS study record update · 2013-03-13
  A Randomized, Open-Label, Parallel-Arm, Optimal Dose-Titration, Multicenter Study to Evaluate the Safety and Efficacy of Oral JNS024 Extended-Release (ER) in Japanese Subjects Treated With Around-the-Clock Opioid Analgesics for Their Moderate to Severe Chronic Malignant Tumor- Related Cancer Pain
• CLINICAL_TRIALS study record update · 2013-03-11
  An Open-label, Non-randomized, Dose Evaluation, Safety and Pharmacokinetics Phase I Study of AVE8062 in Combination With Platinum Salts (Cisplatin or Carboplatin) and Taxanes (Docetaxel or Paclitaxel), Every 3 Weeks, in Patients With Advanced Solid Tumors.
• CLINICAL_TRIALS study record update · 2013-03-08
  A Phase I Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of the Selective Met Inhibitor JNJ-38877605 in Subjects With Advanced or Refractory Solid Tumors
• CLINICAL_TRIALS study record update · 2013-02-11
  Phase I Dose-Escalation Study Of Oral SKI-606 In Subjects With Advanced Malignant Solid Tumors
• CLINICAL_TRIALS study record update · 2013-02-07
  Cancer Survivors Online Self-Management Workshop